Blue Fin Capital’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $318K | Sell |
5,245
-1,611
| -23% | -$93.9K | 0.05% | 128 |
|
|
2025
Q4 | $370K | Sell |
6,856
-283
| -4% | -$13.6K | 0.06% | 122 |
|
|
2025
Q3 | $322K | Sell |
7,139
-74
| -1% | -$3.46K | 0.05% | 126 |
|
|
2025
Q2 | $334K | Hold |
7,213
| – | – | 0.06% | 122 |
|
|
2025
Q1 | $440K | Sell |
7,213
-61
| -0.8% | -$3.56K | 0.09% | 102 |
|
|
2024
Q4 | $411K | Sell |
7,274
-32
| -0.4% | -$1.79K | 0.08% | 105 |
|
|
2024
Q3 | $378K | Hold |
7,306
| – | – | 0.07% | 113 |
|
|
2024
Q2 | $303K | Hold |
7,306
| – | – | 0.06% | 124 |
|
|
2024
Q1 | $396K | Sell |
7,306
-573
| -7% | -$29.2K | 0.09% | 109 |
|
|
2023
Q4 | $404K | Sell |
7,879
-41
| -0.5% | -$2.15K | 0.1% | 101 |
|
|
2023
Q3 | $460K | Sell |
7,920
-109
| -1% | -$6.68K | 0.13% | 93 |
|
|
2023
Q2 | $513K | Hold |
8,029
| – | – | 0.15% | 86 |
|
|
2023
Q1 | $536K | Sell |
8,029
-249
| -3% | -$17.6K | 0.17% | 84 |
|
|
2022
Q4 | $596K | Sell |
8,278
-26
| -0.3% | -$1.96K | 0.22% | 79 |
|
|
2022
Q3 | $590K | Hold |
8,304
| – | – | 0.22% | 78 |
|
|
2022
Q2 | $639K | Sell |
8,304
-168
| -2% | -$12.8K | 0.23% | 74 |
|
|
2022
Q1 | $618K | Sell |
8,472
-36
| -0.4% | -$2.42K | 0.18% | 80 |
|
|
2021
Q4 | $530K | Sell |
8,508
-350
| -4% | -$20.5K | 0.15% | 87 |
|
|
2021
Q3 | $524K | Sell |
8,858
-297
| -3% | -$19.6K | 0.16% | 80 |
|
|
2021
Q2 | $611K | Sell |
9,155
-320
| -3% | -$20.9K | 0.19% | 76 |
|
|
2021
Q1 | $598K | Sell |
9,475
-110
| -1% | -$6.84K | 0.2% | 74 |
|
|
2020
Q4 | $594K | Sell |
9,585
-214
| -2% | -$13.2K | 0.21% | 74 |
|
|
2020
Q3 | $590K | Sell |
9,799
-256
| -3% | -$15.4K | 0.24% | 73 |
|
|
2020
Q2 | $591K | Sell |
10,055
-1,325
| -12% | -$79.3K | 0.26% | 72 |
|
|
2020
Q1 | $634K | Sell |
11,380
-493
| -4% | -$30.1K | 0.35% | 71 |
|
|
2019
Q4 | $762K | Hold |
11,873
| – | – | 0.36% | 77 |
|
|
2019
Q3 | $602K | Sell |
11,873
-1,197
| -9% | -$56.3K | 0.32% | 79 |
|
|
2019
Q2 | $592K | Sell |
13,070
-225
| -2% | -$10.5K | 0.31% | 83 |
|
|
2019
Q1 | $634K | Sell |
13,295
-84
| -0.6% | -$4.18K | 0.33% | 80 |
|
|
2018
Q4 | $695K | Sell |
13,379
-1,331
| -9% | -$71.5K | 0.42% | 68 |
|
|
2018
Q3 | $913K | Sell |
14,710
-1,475
| -9% | -$87.5K | 0.45% | 62 |
|
|
2018
Q2 | $895K | Sell |
16,185
-1,340
| -8% | -$72.4K | 0.48% | 64 |
|
|
2018
Q1 | $1.11M | Buy |
17,525
+380
| +2% | +$24.4K | 0.63% | 47 |
|
|
2017
Q4 | $1.05M | Sell |
17,145
-230
| -1% | -$14.4K | 0.61% | 53 |
|
|
2017
Q3 | $1.11M | Sell |
17,375
-150
| -0.9% | -$8.76K | 0.68% | 44 |
|
|
2017
Q2 | $976K | Sell |
17,525
-1,105
| -6% | -$60.1K | 0.63% | 50 |
|
|
2017
Q1 | $1.01M | Sell |
18,630
-25
| -0.1% | -$1.37K | 0.62% | 51 |
|
|
2016
Q4 | $1.09M | Buy |
18,655
+2,270
| +14% | +$124K | 0.72% | 45 |
|
|
2016
Q3 | $883K | Buy |
16,385
+250
| +2% | +$16.1K | 0.72% | 47 |
|
|
2016
Q2 | $1.19M | Sell |
16,135
-325
| -2% | -$23K | 0.98% | 33 |
|
|
2016
Q1 | $1.05M | Sell |
16,460
-885
| -5% | -$55.8K | 0.89% | 35 |
|
|
2015
Q4 | $1.19M | Sell |
17,345
-180
| -1% | -$11.9K | 0.92% | 34 |
|
|
2015
Q3 | $1.04M | Sell |
17,525
-370
| -2% | -$23.5K | 0.81% | 39 |
|
|
2015
Q2 | $1.19M | Hold |
17,895
| – | – | 0.86% | 32 |
|
|
2015
Q1 | $1.15M | Sell |
17,895
-20
| -0.1% | -$1.25K | 0.83% | 37 |
|
|
2014
Q4 | $1.06M | Buy |
17,915
+520
| +3% | +$29.3K | 0.8% | 45 |
|
|
2014
Q3 | $890K | Buy |
17,395
+375
| +2% | +$18.7K | 0.71% | 48 |
|
|
2014
Q2 | $826K | Buy |
17,020
+700
| +4% | +$34.5K | 0.66% | 54 |
|
|
2014
Q1 | $848K | Sell |
16,320
-877
| -5% | -$46.7K | 0.75% | 45 |
|
|
2013
Q4 | $914K | Buy |
+17,197
| New | +$876K | 0.81% | 40 |
|
Other funds holding BMY
VCM
VPM
Blue Fin Capital's BMY Position: Q1 2026 in Review
Blue Fin Capital reduced its Bristol-Myers Squibb (BMY) stake by 23% in Q1 2026, selling an estimated $93.9K and leaving 5,245 shares worth $318K. The position accounts for 0.05% of the portfolio, ranked #128.
Blue Fin Capital first reported a position in BMY in Q4 2013 and has held it in 50 quarters since. The position peaked at $1.19M in Q4 2015. 2,521 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Blue Fin Capital held 5,245 shares of Bristol-Myers Squibb worth $318K as of Q1 2026.
- Blue Fin Capital sold 1,611 Bristol-Myers Squibb shares in Q1 2026, an estimated $93.9K.
- Bristol-Myers Squibb made up 0.05% of Blue Fin Capital's portfolio in Q1 2026, its #128 holding.
- Blue Fin Capital first reported a position in Bristol-Myers Squibb in Q4 2013 and has held it in 50 quarters since.
- Blue Fin Capital's Bristol-Myers Squibb position peaked at $1.19M in Q4 2015.
- 2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Blue Fin Capital's 13F filing for Q1 2026, filed 28 May 2026.